发明名称 USE OF GENETIC POLYMORPHISMS TO PREDICT DRUG-INDUCED HEPATOTOXICITY.
摘要 <p>ILIA or a gene located near ILIA on chromosome 2q14 may contribute to hepatotoxicity, as measured by increased serum levels of aspartate transaminase, during N-benzoyl-staurosporine treatment for macular edema. Accordingly, genetic polymorphisms in the ILIA gene are useful as biomarkers for predicting staurosporine derivative-mediated hepatotoxicity.</p>
申请公布号 MXPA06003827(A) 申请公布日期 2006.06.14
申请号 MX2006PA03827 申请日期 2004.10.05
申请人 NOVARTIS AG. 发明人 KAREN MCCULLOUGH
分类号 C12Q1/68;(IPC1-7):C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址
您可能感兴趣的专利